DELINIA
Delinia was founded to discover and develop novel therapeutics for the treatment of autoimmune and inflammatory diseases. Delinia’s lead program is a molecule that selectively potentiates and expands regulatory T cells (Tregs), the powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Delinia’s scientific founders and experienced executive leaders are working to advance the company’s initial programs to the clinic.
DELINIA
Industry:
Biotechnology Medical Therapeutics
Founded:
2015-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.deliniabio.com
Total Employee:
11+
Status:
Closed
Contact:
708-555-1234
Email Addresses:
[email protected]
Total Funding:
35 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail ReCAPTCHA Microsoft Azure DNS Proofpoint CSC Global DNS
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
NFlection Therapeutics
NFlection focuses on the development of novel therapies to address the needs of patients.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Current Advisors List
Founder
Investors List
Sofinnova Partners
Sofinnova Partners investment in Series A - Delinia
Atlas Venture
Atlas Venture investment in Series A - Delinia
Official Site Inspections
http://www.deliniabio.com
- Host name: 165.160.13.20
- IP address: 165.160.13.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
